Merck KGaA (ETR:MRK - Get Free Report)'s share price traded up 2% during trading on Friday . The company traded as high as €151.70 ($156.39) and last traded at €151.50 ($156.19). 186,591 shares traded hands during mid-day trading, The stock had previously closed at €148.50 ($153.09).
Merck KGaA Stock Down 1.3 %
The company has a current ratio of 1.31, a quick ratio of 0.72 and a debt-to-equity ratio of 37.56. The firm has a market capitalization of $18.67 billion, a price-to-earnings ratio of 23.92, a price-to-earnings-growth ratio of 2.37 and a beta of 0.71. The firm has a 50 day moving average price of €142.10 and a two-hundred day moving average price of €153.75.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Further Reading
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
